| Literature DB >> 34218594 |
Sunghee Park1, Jiwon Jung1, Yong Pil Chong1, Sung-Han Kim1, Sang-Oh Lee1, Sang-Ho Choi1, Yang Soo Kim1, Min Jae Kim1.
Abstract
Eosinophilic meningitis is defined as the presence of more than 10 eosinophils per μl in the cerebrospinal fluid (CSF), or eosinophils accounting for more than 10% of CSF leukocytes in patients with acute meningitis. Parasites are the most common cause of eosinophilic meningitis worldwide, but there is limited research on patients in Korea. Patients diagnosed with eosinophilic meningitis between January 2004 and June 2018 at a tertiary hospital in Seoul, Korea were retrospectively reviewed. The etiology and clinical characteristics of each patient were identified. Of the 22 patients included in the study, 11 (50%) had parasitic causes, of whom 8 (36%) were diagnosed as neurocysticercosis and 3 (14%) as Toxocara meningitis. Four (18%) patients were diagnosed with fungal meningitis, and underlying immunodeficiency was found in 2 of these patients. The etiology of another 4 (18%) patients was suspected to be tuberculosis, which is endemic in Korea. Viral and bacterial meningitis were relatively rare causes of eosinophilic meningitis, accounting for 2 (9%) and 1 (5%) patients, respectively. One patient with neurocysticercosis and 1 patient with fungal meningitis died, and 5 (23%) had neurologic sequelae. Parasite infections, especially neurocysticercosis and toxocariasis, were the most common cause of eosinophilic meningitis in Korean patients. Fungal meningitis, while relatively rare, is often aggressive and must be considered when searching for the cause of eosinophilic meningitis.Entities:
Keywords: Eosinophilic meningitis; Korea; etiology
Year: 2021 PMID: 34218594 PMCID: PMC8255497 DOI: 10.3347/kjp.2021.59.3.227
Source DB: PubMed Journal: Korean J Parasitol ISSN: 0023-4001 Impact factor: 1.341
Clinical and radiologic characteristics of patients with eosinophilic meningitis according to different etiology
| Total (n=22) | Neurocysticercosis (n=8) | Toxocariasis (n=3) | Fungal (n=4) | Tuberculosis (n=4) | Viral (n=2) | Bacterial (n=1) | |
|---|---|---|---|---|---|---|---|
| Age at diagnosis (years) | 42.4±21.2 | 59.9±11.2 | 33.7±1.5 | 37.8±30.1 | 40.0±14.4 | 20.5±12.0 | 0.5 |
|
| |||||||
| Male sex | 16 (73) | 6 (75) | 3 (100) | 2 (50) | 3 (75) | 1 (50) | 1 (100) |
|
| |||||||
| History of overseas travel within 5 years | 4 (18) | 0 (0) | 2 (67) | 1 (25) | 0 (0) | 1 (50) | 0 (0) |
|
| |||||||
| History of raw food ingestion | 4 (18) | 1 (13) | 3 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
|
| |||||||
| Symptoms or signs | |||||||
| Headache | 15 (68) | 3 (38) | 3 (100) | 3 (75) | 4 (100) | 2 (100) | 0 (0) |
| Vomiting | 9 (41) | 0 (0) | 1 (33) | 3 (75) | 2 (50) | 2 (100) | 1 (100) |
| Fever | 8 (36) | 0 (0) | 2 (67) | 2 (50) | 2 (50) | 1 (50) | 1 (100) |
| Cranial nerve palsy | 1 (5) | 0 (0) | 0 (0) | 1 (25) | 0 (0) | 0 (0) | 0 (0) |
| Dizziness | 3 (14) | 1 (13) | 0 (0) | 0 (0) | 2 (50) | 0 (0) | 0 (0) |
| Altered consciousness | 4 (18) | 1 (13) | 0 (0) | 1 (25) | 2 (50) | 0 (0) | 0 (0) |
| Gait disturbance | 6 (27) | 4 (50) | 0 (0) | 1 (25) | 1 (25) | 0 (0) | 0 (0) |
| Neck stiffness | 6 (27) | 1 (13) | 1 (33) | 1 (25) | 2 (50) | 1 (50) | 0 (0) |
|
| |||||||
| CSF analysis | |||||||
| WBC count (cells/μl) | 95.0 (34.8–267.5) | 50.0 (28.3–140.0) | 680.0 (400.0–840.0) | 195.0 (75.8–301.8) | 162.0 (92.5–282.5) | 21.5 (16.8–26.3) | 45.0 |
| Eosinophil (%) | 18.0 (16.0–29.3) | 16.0 (13.3–19.8) | 54.0 (45.0–63.5) | 19.5 (18.8–29.3) | 17.0 (16.8–20.3) | 27.5 (19.3–35.8) | 16.0 |
| Protein (mg/dl) | 83.1 (60.9–134.7) | 89.3 (75.9–98.8) | 66.8 (55.8–75.0) | 88.4 (60.6–120.5) | 160.3 (125.4–196.4) | 49.1 (45.8–52.3) | 178.7 |
| Glucose (mg/dl) | 48.5 (44.0–61.0) | 52.0 (37.0–63.3) | 55.0 (52.0–61.5) | 44.0 (41.8–46.0) | 38.5 (27.0–48.3) | 62.0 (61.5–62.5) | 46.0 |
|
| |||||||
| Peripheral blood eosinophilia | 6 (27) | 0 (0) | 3 (100) | 1 (25) | 1 (25) | 1 (50) | 0 (0) |
|
| |||||||
| Brain imaging findings | |||||||
| Meningeal enhancement | 11 (50) | 2 (25) | 1 (33) | 3 (75) | 4 (100) | 0 (0) | 1 (100) |
| Hydrocephalus | 8 (36) | 7 (88) | 0 (0) | 1 (25) | 0 (0) | 0 (0) | 0 (0) |
| Acute infarction | 4 (18) | 0 (0) | 0 (0) | 2 (50) | 2 (50) | 0 (0) | 0 (0) |
|
| |||||||
| Steroid treatment | 15 (68) | 5 (63) | 3 (100) | 4 (100) | 3 (75) | 0 (0) | 0 (0) |
|
| |||||||
| Deaths | 2 (9) | 1 (13) | 0 (0) | 1 (25) | 0 (0) | 0 (0) | 0 (0) |
|
| |||||||
| Neurologic sequelae | 5 (23) | 5 (63) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
CSF, cerebrospinal fluid; WBC, white blood cell.
Data are expressed as mean±standard deviation, median (interquartile range), or number (%).
Fig. 1Brain magnetic resonance imaging (MRI) of a patient diagnosed with neurocysticercosis. (A) Multiple cystic lesions with focal wall enhancement are seen at both frontal base and subcallosal areas, suggestive of parasitic cysts (red arrowheads). (B) Ventriculomegaly of both lateral ventricles (red arrows) can be seen.
Fig. 2Chest radiograph of a neurocysticercosis patient. Numerous small calcific lesions in the soft tissue can be seen, suggestive of calcified granulomas related to cysticercosis (easily found in the yellow rectangular areas).